These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17578456)

  • 1. Does cyclosporine inhibit in vivo hepatitis C virus replication?--a pilot study.
    Wawrzynowicz-Syczewska M; Herman E; Jurczyk K; Karpińska E; Laurans Ł; Lubikowski J; Boroń-Kaczmarska A
    Transpl Int; 2007 Sep; 20(9):808-10. PubMed ID: 17578456
    [No Abstract]   [Full Text] [Related]  

  • 2. Review article: hepatitis C virus and calcineurin inhibition after renal transplantation.
    Fabrizi F; Bromberg J; Elli A; Dixit V; Martin P
    Aliment Pharmacol Ther; 2005 Oct; 22(8):657-66. PubMed ID: 16197487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.
    Guitard J; Sandres-Sauné K; Kamar N; Ribes D; Faguer S; Esposito L; Lavit M; Muscari F; Péron JM; Lavayssière L; Durand D; Rostaing L
    Transplant Proc; 2007 Oct; 39(8):2603-5. PubMed ID: 17954189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of progressive hepatitis C following liver transplantation.
    Davis GL
    Liver Transpl; 2006 Jan; 12(1):19-21. PubMed ID: 16382454
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
    Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
    AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy.
    Nanmoku K; Imaizumi R; Tojimbara T; Nakajima I; Fuchinoue S; Sakamoto N; Watanabe M; Teraoka S
    Transplant Proc; 2008 Sep; 40(7):2382-5. PubMed ID: 18790241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes.
    McCaughan GW; Shackel NA; Bertolino P; Bowen DG
    Transplantation; 2009 Apr; 87(8):1105-11. PubMed ID: 19384153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus-infected renal transplant patients.
    Schiavon LL; Carvalho-Filho RJ; Narciso-Schiavon JL; Barbosa DV; Lanzoni VP; Ferraz ML; Silva AE
    Hepatology; 2008 Jul; 48(1):348-9. PubMed ID: 18521870
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection?
    Manna R; Verrecchia E; Fonnesu C; Giovinale M; De Socio G; Curigliano V; Cerquaglia C; Soriano A; Granata M; Migliore A; Massafra U; Gasbarrini G
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():63-9. PubMed ID: 19530514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters?
    Kuo A; Terrault NA
    J Hepatol; 2007 Mar; 46(3):359-61. PubMed ID: 17223220
    [No Abstract]   [Full Text] [Related]  

  • 11. Human immunodeficiency virus and liver transplantation: our point of view.
    Di Benedetto F; Di Sandro S; De Ruvo N; Berretta M; Montalti R; Guerrini GP; Ballarin R; De Blasiis MG; Spaggiari M; Smerieri N; Iemmolo RM; Guaraldi G; Gerunda GE
    Transplant Proc; 2008; 40(6):1965-71. PubMed ID: 18675102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of fulminant hepatitis C or subacute hepatitis C].
    Inoue K; Yoshiba M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):371-5. PubMed ID: 15359824
    [No Abstract]   [Full Text] [Related]  

  • 13. Perioperative viral kinetics: new insights or the Emperor's new clothes?
    Charlton M
    Liver Transpl; 2006 Feb; 12(2):194-5. PubMed ID: 16447194
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
    Cescon M; Grazi GL; Cucchetti A; Vetrone G; Ravaioli M; Ercolani G; Morelli MC; Piscaglia F; Tamè M; Pinna AD
    Liver Transpl; 2009 Jul; 15(7):782-9. PubMed ID: 19562715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interfering with interferon: re-igniting the debate on calcineurin inhibitor choice and antiviral therapy for hepatitis C virus recurrence.
    Watashi K; Metselaar HJ; van der Laan LJ
    Liver Transpl; 2008 Mar; 14(3):265-7. PubMed ID: 18306373
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there a link between hepatitis C virus and new onset of diabetes mellitus after liver transplantation?
    Thuluvath PJ
    Liver Transpl; 2007 Jan; 13(1):5-7. PubMed ID: 17192890
    [No Abstract]   [Full Text] [Related]  

  • 17. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
    Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
    Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New efficient replication system with hepatitis C virus genome derived from a patient with acute hepatitis C.
    Mori K; Abe K; Dansako H; Ariumi Y; Ikeda M; Kato N
    Biochem Biophys Res Commun; 2008 Jun; 371(1):104-9. PubMed ID: 18406345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of steroids on hepatitis C virus replication in vivo and in vitro.
    Henry SD; Metselaar HJ; Van Dijck J; Tilanus HW; Van Der Laan LJ
    Ann N Y Acad Sci; 2007 Sep; 1110():439-47. PubMed ID: 17911459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.